The FPR2-mediated anti-apoptotic function of rhSAA was initially demonstrated within the context of arthritic diseases, where RA-derived and OA-derived fibroblast-like synoviocytes (FLS) showed increased proliferation, following treatment with rhSAA. The gene discussed is FPR2; the disease is rheumatoid arthritis.